Why Why Crypto-Related Stocks MicroStrategy, Argo Blockchain And Bit Digital Are Moving Higher

Several crypto-related stocks including MicroStrategy, Inc. (NASDAQ: MSTR), Bit Digital, Inc. (NASDAQ: BTBT) and Argo Blockchain, Plc. (NASDAQ:

Several crypto-related stocks including MicroStrategy, Inc. (NASDAQ:MSTR), Bit Digital, Inc. (NASDAQ:BTBT) and Argo Blockchain, Plc. (NASDAQ:ARBK) are climbing on Wednesday fueled by gains in the crypto market, led by Bitcoin (CRYPTO: BTC) and Ethereum (CRYPTO: ETH).

What To Know:

The crypto market is moving higher after multiple positive developments including the launch of a new exchange, EDX Markets. The EDX Markets exchange is backed by some traditionally respected and well-known names in the finance world including Charles Schwab, Fidelity and Citadel Securities. 

The EDX Markets launch comes just days after BlackRock filed an application for a spot Bitcoin ETF. BlackRock has an outstanding record of approvals on ETF applications, and if approved, the Blackrock spot Bitcoin ETF would be the first in the U.S.

MicroStrategy is an analytics and business intelligence company. The stock was up nearly 6% at $332.03 at the time of publication.

Argo Blockchain is a UK-based blockchain company that provides a platform for cryptocurrency mining operations. The stock was up over 20% at $1.40 at last check.

Bit Digital is a digital asset mining company with operations in the U.S. and Canada. Shares were up over 5% at $4.06 on Wednesday.

Related News: Why Ocean Biomedical (OCEA) Shares Are Climbing Wednesday

BTC and ETH Price Action: According to Benzinga Pro, Bitcoin is trading 11% higher over a 24 hour period at $30,302.88 and Ethereum is 8.5% higher at $1855.51 at the time of publication.

Image: WorldSpectrom from Pixabay

Total
0
Shares
Related Posts
Read More

EXCLUSIVE: Europe Is The Biggest Opportunity For Growth In The Cannabis Sector,’ Curaleaf’s Boris Jordan Tells Benzinga Cannabis Capital Conference

"Europe is the biggest opportunity for growth in the cannabis sector in the next five years," said Boris Jordan, founder and executive chairman of the board of Curaleaf Holdings Inc (OTCQX: CURLF) to the

CURLF

Read More

Intellia Therapeutics Highlights Its 3-Year Strategic Priorities And Anticipated 2024 Key Milestones; Ended 2023 In A Strong Financial Position With Approximately $1B In Cash; Cash Runway Extended Into Mid-2026

Core priorities through 2026 include completion of Phase 3 study and BLA submission for NTLA-2002, completion of patient enrollment in the pivotal study of NTLA-2001, clinical validation of modular in vivo gene insertion

NTLA